Either to replace BP measurements on the day of a clinic or so that BP measurements may be done more frequently.
Provides an easy to use system for women, many of whom already informally self-monitor.
Provides advice on what a woman should do depending on her BP levels.
Women with chronic hypertension, gestational hypertension, pre-eclampsia
Women determined as high or moderate risk by NICE guidelines (see below)
All pregnant women (including those who may need to self-isolate for a period)
*NICE guideline [NG133] “Hypertension in pregnancy:diagnosis and management” published June 2019: www.nice.org.uk/guidance/ng133
Provides women with advice about blood pressure levels.
Self- monitoring gives pregnant women greater control of their pregnancy care while potentially reducing the need for face-to-face clinic visits
Helps mums-to-be self-monitor blood pressure to protect themselves and their baby.
Provides an easy to use and uniform monitoring system for healthcare professionals.
Reduces face-to-face contact to reduce risk associated with COVID-19 infection.
All patient data is anonymised, securely stored on the cloud as a completely isolated instance with rigorous data security and privacy measures.
Note: Not all Sensyne Health products are available in all territories, for further information contact head office.
McManus RJ, Mant J,Franssen M, Nickless A, Schwartz C, Hodgkinson J, et al. Efficacy of self-monitored blood pressure, with or without telemonitoring, for titration of antihypertensive medication (TASMINH4): an unmasked randomised controlled trial. Lancet. 2018; 391(10124):949-59.
McManus RJ, Mant J, Bray EP, Holder R, Jones MI, Greenfield S, et al. Telemonitoring and self-management in the control of hypertension (TASMINH2): a randomised controlled trial. Lancet. 2010; 376(9736):163-72.
McManus RJ, Mant J, Haque MS, Bray EP, Bryan S, Greenfield SM, et al. Effect of self-monitoring and medication self-titration on systolic blood pressure in hypertensive patients at high risk of cardiovascular disease: the TASMIN-SR randomized clinical trial. JAMA. 2014 ;312(8):799-808.
Pealing LM, Tucker KL, Mackillop LH, Crawford C, Wilson H, Nickless A, et al. A randomised controlled trial of blood pressure self-monitoring in the management of hypertensive pregnancy. OPTIMUM-BP: A feasibility trial. Pregnancy Hypertens. 2019; 18:141-9.
Cairns AE, Tucker KL, Leeson P, Mackillop LH, Santos M, Velardo C, et al. Self-Management of Postnatal Hypertension: The SNAP-HT Trial. Hypertension. 2018.
Tucker KL, Taylor KS, Crawford C, Hodgkinson JA, Bankhead C, Carver T, et al. Blood pressure self-monitoring in pregnancy: examining feasibility in a prospective cohort study. BMC Pregnancy Childbirth. 2017; 17(1):442.
Hinton L, Tucker KL, Greenfield SM, Hodgkinson JA, Mackillop L, McCourt C, et al.Blood pressure self-monitoring in pregnancy (BuMP) feasibility study; a qualitative analysis of women's experiences of self-monitoring. BMC Pregnancy Childbirth. 2017; 17(1):427.
Grant S, Hodgkinson J, Schwartz C, Bradburn P, Franssen M, Hobbs FR, et al. Using mHealth for the management of hypertension in UK primary care: an embedded qualitative study of the TASMINH4 randomised controlled trial. Br J Gen Pract. 2019; 69(686):e612-e20.
Jones MI, Greenfield SM, Bray EP, Baral-Grant S, Hobbs FD, Holder R, et al. Patients' experiences of self-monitoring blood pressure and self-titration of medication: the TASMINH2 trial qualitative study. Br J Gen Pract. 2012; 62(595):e135-e42.